vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and SOLAREDGE TECHNOLOGIES, INC. (SEDG). Click either name above to swap in a different company.
SOLAREDGE TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($335.4M vs $270.8M, roughly 1.2× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -39.4%, a 40.1% gap on every dollar of revenue. On growth, SOLAREDGE TECHNOLOGIES, INC. posted the faster year-over-year revenue change (70.9% vs -16.5%). SOLAREDGE TECHNOLOGIES, INC. produced more free cash flow last quarter ($43.3M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
SolarEdge Technologies, Inc. is an Israeli company that developed a DC optimized inverter system.
HCM vs SEDG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $335.4M |
| Net Profit | $2.0M | $-132.1M |
| Gross Margin | 37.7% | 22.2% |
| Operating Margin | -13.2% | -14.4% |
| Net Margin | 0.7% | -39.4% |
| Revenue YoY | -16.5% | 70.9% |
| Net Profit YoY | -83.6% | 54.0% |
| EPS (diluted) | $0.00 | $-2.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $335.4M | ||
| Q3 25 | — | $340.2M | ||
| Q2 25 | $277.7M | $289.4M | ||
| Q1 25 | $324.5M | $219.5M | ||
| Q4 24 | — | $196.2M | ||
| Q3 24 | — | $235.4M | ||
| Q2 24 | $305.7M | $265.4M | ||
| Q1 24 | — | $204.4M |
| Q4 25 | $2.0M | $-132.1M | ||
| Q3 25 | — | $-50.1M | ||
| Q2 25 | $455.0M | $-124.7M | ||
| Q1 25 | $11.9M | $-98.5M | ||
| Q4 24 | — | $-287.4M | ||
| Q3 24 | — | $-1.2B | ||
| Q2 24 | $25.8M | $-130.8M | ||
| Q1 24 | — | $-157.3M |
| Q4 25 | 37.7% | 22.2% | ||
| Q3 25 | — | 21.2% | ||
| Q2 25 | 0.1% | 11.1% | ||
| Q1 25 | 48.0% | 8.0% | ||
| Q4 24 | — | -57.2% | ||
| Q3 24 | — | -309.1% | ||
| Q2 24 | 41.1% | -4.1% | ||
| Q1 24 | — | -12.8% |
| Q4 25 | -13.2% | -14.4% | ||
| Q3 25 | — | -10.3% | ||
| Q2 25 | -1.3% | -39.9% | ||
| Q1 25 | -5.0% | -46.8% | ||
| Q4 24 | — | -134.4% | ||
| Q3 24 | — | -471.8% | ||
| Q2 24 | -9.0% | -60.4% | ||
| Q1 24 | — | -85.0% |
| Q4 25 | 0.7% | -39.4% | ||
| Q3 25 | — | -14.7% | ||
| Q2 25 | 163.8% | -43.1% | ||
| Q1 25 | 3.7% | -44.9% | ||
| Q4 24 | — | -146.5% | ||
| Q3 24 | — | -522.8% | ||
| Q2 24 | 8.4% | -49.3% | ||
| Q1 24 | — | -77.0% |
| Q4 25 | $0.00 | $-2.21 | ||
| Q3 25 | — | $-0.84 | ||
| Q2 25 | $0.52 | $-2.13 | ||
| Q1 25 | $0.01 | $-1.70 | ||
| Q4 24 | — | $-5.00 | ||
| Q3 24 | — | $-21.58 | ||
| Q2 24 | $0.03 | $-2.31 | ||
| Q1 24 | — | $-2.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $493.2M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $427.5M |
| Total Assets | $1.8B | $2.2B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $493.2M | ||
| Q3 25 | — | $498.6M | ||
| Q2 25 | $1.4B | $758.0M | ||
| Q1 25 | $836.1M | $651.6M | ||
| Q4 24 | — | $585.9M | ||
| Q3 24 | — | $678.8M | ||
| Q2 24 | $802.5M | $689.8M | ||
| Q1 24 | — | $680.6M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $427.5M | ||
| Q3 25 | — | $479.8M | ||
| Q2 25 | $1.2B | $513.2M | ||
| Q1 25 | $759.9M | $594.2M | ||
| Q4 24 | — | $658.3M | ||
| Q3 24 | — | $930.9M | ||
| Q2 24 | $740.1M | $2.1B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $1.8B | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $1.8B | $2.5B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | $1.3B | $3.9B | ||
| Q1 24 | — | $4.2B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $52.6M |
| Free Cash FlowOCF − Capex | $3.4M | $43.3M |
| FCF MarginFCF / Revenue | 1.2% | 12.9% |
| Capex IntensityCapex / Revenue | 1.8% | 2.8% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $80.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $52.6M | ||
| Q3 25 | — | $25.6M | ||
| Q2 25 | $-72.9M | $-7.8M | ||
| Q1 25 | $40.3M | $33.8M | ||
| Q4 24 | — | $37.8M | ||
| Q3 24 | — | $-89.3M | ||
| Q2 24 | $-39.8M | $-44.8M | ||
| Q1 24 | — | $-217.0M |
| Q4 25 | $3.4M | $43.3M | ||
| Q3 25 | — | $22.8M | ||
| Q2 25 | $-82.2M | $-9.1M | ||
| Q1 25 | $32.5M | $23.7M | ||
| Q4 24 | — | $25.5M | ||
| Q3 24 | — | $-136.7M | ||
| Q2 24 | $-49.9M | $-67.0M | ||
| Q1 24 | — | $-243.4M |
| Q4 25 | 1.2% | 12.9% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | -29.6% | -3.1% | ||
| Q1 25 | 10.0% | 10.8% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | -58.1% | ||
| Q2 24 | -16.3% | -25.2% | ||
| Q1 24 | — | -119.1% |
| Q4 25 | 1.8% | 2.8% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | 3.3% | 0.4% | ||
| Q1 25 | 2.4% | 4.6% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | 3.3% | 8.4% | ||
| Q1 24 | — | 12.9% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
SEDG
| Other | $197.7M | 59% |
| Europe Except Netherlands | $99.4M | 30% |
| Others | $38.2M | 11% |
